Recovery · Compounded
One prescribed peptide, one clinical review, ongoing care.
BPC-157, prescribed by a licensed U.S. provider after a clinical review and prepared for you by a licensed U.S. compounding pharmacy, with follow-up from your care team.
$179/mo · $537 for 90 daysShipping and cold-chain included. Prepaid multi-month pricing is locked at purchase.
Compounded medications are prepared by licensed U.S. compounding pharmacies for an individual patient under a prescription. They are not approved by the FDA and have not been evaluated by the FDA for safety, effectiveness, or quality.
Risen MD is your covered entity; intake runs on a HIPAA-compliant, BAA-backed platform.
How it works
Three steps, every program.
The clinical review is never skipped, whatever you come here for.
- Intake.A private form inside a secure, HIPAA-compliant platform.
- Licensed-provider review.A licensed U.S. provider evaluates your intake and decides on treatment, which is never guaranteed.
- Ongoing care.If prescribed, medication ships from a licensed U.S. pharmacy and your care team follows up.
What is in this program
One peptide therapy program with a single peptide.
This program is a single prescribed peptide, BPC-157 — a synthetic peptide based on a sequence found in human gastric juice. It is prescription-only, it is prepared for one named patient by a licensed U.S. compounding pharmacy, and it is not FDA-approved.
Because BPC-157 is not FDA-approved, there is no approved labeling for us to quote — so this page does not state what it will do for you. That is a deliberate choice rather than an omission: a statement about what a treatment will do belongs to the licensed provider who has read your history, and to nobody else.
What this page can tell you is how the decision gets made. A licensed provider reviews your intake and decides whether a peptide program is appropriate for you at all, and what it is intended to do in your case. Ask your provider that question directly — it is the one they are there to answer.
Evidence and sources
What the sources say.
Every clinical statement on this page carries its source and the date it was last reviewed.
- A 503A compounding pharmacy prepares a medication for an individual patient under a prescription.
Safety and candor
Not for everyone — and that is the point of the review.
Compounded medications are prepared by licensed U.S. compounding pharmacies for an individual patient under a prescription. They are not approved by the FDA and have not been evaluated by the FDA for safety, effectiveness, or quality. Compounded medications have not been evaluated by the FDA for safety or effectiveness.
Not for people with
- Pregnancy, planning pregnancy, or breastfeeding
- Active cancer or a history of cancer (discuss with your provider)
- Known hypersensitivity to the formulation
Treatment, prescriptions, and eligibility are determined by a licensed provider following an evaluation, and are never guaranteed.
FAQ
Questions
Is this FDA-approved?
No. Compounded medications are prepared for an individual patient under a prescription and are not FDA-approved. A licensed provider decides whether this program is appropriate for you.
What is BPC-157?
A synthetic peptide based on a sequence found in human gastric juice. It is prescription-only and prepared for one named patient by a licensed U.S. compounding pharmacy.
Who decides whether I can start?
A licensed U.S. provider, after reviewing your intake and medical history. Treatment is never guaranteed, and it is not decided by Risen MD. If a peptide program is not appropriate for you, your provider will tell you.